EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of lipid-lowering treatment on the performance of SCORE2 algorithms in detecting high-risk individuals

Anastasios Kollias, Konstantinos G Kyriakoulis, Aikaterini Komnianou, Thomas Tsaganos, Dimitra Krystallaki, Ariadni Menti, Eirini-Chrysovalanti Antonogiannaki, George S Stergiou

Nutrition, Metabolism and Cardiovascular Diseases · 2026

DOI: 10.1016/j.numecd.2026.104823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Anastasios Kollias und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Ath…. Hauptthemen laut MEDLINE: Dyslipidemias, Algorithms, Hypolipidemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Academic Libraries Link, National and Kapodistrian University of Athens.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Current guidelines state that Systematic Coronary Risk Evaluation 2 (SCORE2) risk algorithms should not be used among persons under lipid-lowering therapy. This study investigated, among dyslipidemia-treated individuals, the effect of lipid-lowering treatment on SCORE2 calculation and on its performance in detecting high-risk individuals METHODS AND RESULTS: Analysis included middle-aged individuals (n = 417), treated for dyslipidemia, without established cardiovascular disease, diabetes and/or chronic kidney disease, recruited from screening programs in the community [mean age 59.5 ± 6.9 (SD) years, men 48.9%, statin monotherapy 67%, statin/ezetimibe combination 26%]. SCORE2 algorithms were calculated using measured and adjusted (for the lipid-lowering therapy characteristics) lipid levels. SCORE2 and adjusted-SCORE2 were 5.4 ± 2.7% and 6.6 ± 3.3% respectively (P < 0.05). Participants classified as low-moderate/high/very-high risk (age-dependent risk thresholds) were 42.2%/51.1%/6.7% with SCORE2, and 28.8%/54.4%/16.8% with adjusted-SCORE2 (agreement 76.5%, weighted kappa 0.73, P < 0.05). Using single risk thresholds (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasAlgorithmsHypolipidemic AgentsHumansMaleMiddle AgedRisk AssessmentFemaleAgedHydroxymethylglutaryl-CoA Reductase InhibitorsPrediction AlgorithmsPredictive Value of TestsHeart Disease Risk FactorsRisk FactorsLipidsBiomarkers

Substanzen

Hypolipidemic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsBiomarkers

Autor:innen und Institutionen

  • Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece. Electronic address: taskollias@gmail.com.
  • Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece.

Förderung

  • Hellenic Academic Libraries Link
  • National and Kapodistrian University of Athens

Zitieren

APA

Kollias, A., Kyriakoulis, K. G., Komnianou, A., Tsaganos, T., Krystallaki, D., Menti, A., Antonogiannaki, E. C., & Stergiou, G. S. (2026). Impact of lipid-lowering treatment on the performance of SCORE2 algorithms in detecting high-risk individuals. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2026.104823

Vancouver

Kollias A, Kyriakoulis KG, Komnianou A, Tsaganos T, Krystallaki D, Menti A, et al. Impact of lipid-lowering treatment on the performance of SCORE2 algorithms in detecting high-risk individuals. Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2026.104823

BibTeX
@article{Kollias2026,
  author = {Kollias, Anastasios and Kyriakoulis, Konstantinos G and Komnianou, Aikaterini and Tsaganos, Thomas and Krystallaki, Dimitra and Menti, Ariadni and Antonogiannaki, Eirini-Chrysovalanti and Stergiou, George S},
  title = {Impact of lipid-lowering treatment on the performance of SCORE2 algorithms in detecting high-risk individuals},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.numecd.2026.104823}
}
Kostenlos starten →